(NASDAQ: KPRX) Kiora Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.3%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.73%.
Kiora Pharmaceuticals's earnings in 2025 is -$12,051,454.On average, 1 Wall Street analyst forecast KPRX's earnings for 2025 to be -$6,787,801, with the lowest KPRX earnings forecast at -$6,787,801, and the highest KPRX earnings forecast at -$6,787,801.
In 2026, KPRX is forecast to generate -$7,183,503 in earnings, with the lowest earnings forecast at -$7,183,503 and the highest earnings forecast at -$7,183,503.